Synthesis and biological evaluation of non-peptide alpha(v)beta(3)/alpha(5)beta(1) integrin dual antagonists containing 5,6-dihydropyridin-2-one scaffolds. 2007

Fides Benfatti, and Giuliana Cardillo, and Serena Fabbroni, and Patrizia Galzerano, and Luca Gentilucci, and Riccardo Juris, and Alessandra Tolomelli, and Monica Baiula, and Antonino Spartà, and Santi Spampinato
Dipartimento di Chimica "G. Ciamician", Università di Bologna, Via Selmi 2, 40126 Bologna, Italy.

Small constrained non-peptidic molecules consisting of a polyfunctionalized rigid core, carrying appendages corresponding to arginine and aspartic acid side chains, have been recently reported to be promising for drug development. In this work, the 5,6-dihydropyridin-2-one was envisaged as a scaffold to turn into potential integrin ligands, introducing a carboxylic acid and a basic appendage. The synthesis and the antiadhesion activity of a small library of peptidomimetics capable to recognize alpha(v)beta(3) and alpha(5)beta(1) integrins has been herein reported.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Fides Benfatti, and Giuliana Cardillo, and Serena Fabbroni, and Patrizia Galzerano, and Luca Gentilucci, and Riccardo Juris, and Alessandra Tolomelli, and Monica Baiula, and Antonino Spartà, and Santi Spampinato
January 2004, Bioorganic & medicinal chemistry letters,
Fides Benfatti, and Giuliana Cardillo, and Serena Fabbroni, and Patrizia Galzerano, and Luca Gentilucci, and Riccardo Juris, and Alessandra Tolomelli, and Monica Baiula, and Antonino Spartà, and Santi Spampinato
January 2009, Bioorganic & medicinal chemistry letters,
Fides Benfatti, and Giuliana Cardillo, and Serena Fabbroni, and Patrizia Galzerano, and Luca Gentilucci, and Riccardo Juris, and Alessandra Tolomelli, and Monica Baiula, and Antonino Spartà, and Santi Spampinato
January 2010, Journal of medicinal chemistry,
Fides Benfatti, and Giuliana Cardillo, and Serena Fabbroni, and Patrizia Galzerano, and Luca Gentilucci, and Riccardo Juris, and Alessandra Tolomelli, and Monica Baiula, and Antonino Spartà, and Santi Spampinato
August 2010, Bioorganic & medicinal chemistry letters,
Fides Benfatti, and Giuliana Cardillo, and Serena Fabbroni, and Patrizia Galzerano, and Luca Gentilucci, and Riccardo Juris, and Alessandra Tolomelli, and Monica Baiula, and Antonino Spartà, and Santi Spampinato
August 2003, Cancer biotherapy & radiopharmaceuticals,
Fides Benfatti, and Giuliana Cardillo, and Serena Fabbroni, and Patrizia Galzerano, and Luca Gentilucci, and Riccardo Juris, and Alessandra Tolomelli, and Monica Baiula, and Antonino Spartà, and Santi Spampinato
January 1996, American journal of nephrology,
Fides Benfatti, and Giuliana Cardillo, and Serena Fabbroni, and Patrizia Galzerano, and Luca Gentilucci, and Riccardo Juris, and Alessandra Tolomelli, and Monica Baiula, and Antonino Spartà, and Santi Spampinato
October 2000, Journal of medicinal chemistry,
Fides Benfatti, and Giuliana Cardillo, and Serena Fabbroni, and Patrizia Galzerano, and Luca Gentilucci, and Riccardo Juris, and Alessandra Tolomelli, and Monica Baiula, and Antonino Spartà, and Santi Spampinato
September 2004, Bioorganic & medicinal chemistry letters,
Fides Benfatti, and Giuliana Cardillo, and Serena Fabbroni, and Patrizia Galzerano, and Luca Gentilucci, and Riccardo Juris, and Alessandra Tolomelli, and Monica Baiula, and Antonino Spartà, and Santi Spampinato
February 2004, Bioorganic & medicinal chemistry letters,
Fides Benfatti, and Giuliana Cardillo, and Serena Fabbroni, and Patrizia Galzerano, and Luca Gentilucci, and Riccardo Juris, and Alessandra Tolomelli, and Monica Baiula, and Antonino Spartà, and Santi Spampinato
January 2000, Journal of medicinal chemistry,
Copied contents to your clipboard!